Does the media refer more to IDXX or NVST?

In the previous week, IDEXX Laboratories had 14 more articles in the media than Envista. MarketBeat recorded 16 mentions for IDEXX Laboratories and 2 mentions for Envista. IDEXX Laboratories' average media sentiment score of 1.20 beat Envista's score of 0.72 indicating that IDEXX Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 10 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer IDXX or ABT?

In the previous week, Abbott Laboratories had 76 more articles in the media than IDEXX Laboratories. MarketBeat recorded 92 mentions for Abbott Laboratories and 16 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.20 beat Abbott Laboratories' score of 1.02 indicating that IDEXX Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 10 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Abbott Laboratories 54 Very Positive mention(s) 11 Positive mention(s) 15 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ISRG or IDXX?

In the previous week, Intuitive Surgical had 79 more articles in the media than IDEXX Laboratories. MarketBeat recorded 95 mentions for Intuitive Surgical and 16 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.20 beat Intuitive Surgical's score of 0.72 indicating that IDEXX Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intuitive Surgical 33 Very Positive mention(s) 13 Positive mention(s) 17 Neutral mention(s) 19 Negative mention(s) 0 Very Negative mention(s) Positive IDEXX Laboratories 10 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, SYK or IDXX?

Stryker has higher revenue and earnings than IDEXX Laboratories. Stryker is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Stryker $25.12B 4.90 $3.25B $8.64 37.17 IDEXX Laboratories $4.30B 10.36 $1.06B $13.58 41.62

Does the media refer more to SYK or IDXX?

In the previous week, Stryker had 18 more articles in the media than IDEXX Laboratories. MarketBeat recorded 34 mentions for Stryker and 16 mentions for IDEXX Laboratories. Stryker's average media sentiment score of 1.30 beat IDEXX Laboratories' score of 1.20 indicating that Stryker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stryker 26 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IDEXX Laboratories 10 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MDT or IDXX?

In the previous week, Medtronic had 10 more articles in the media than IDEXX Laboratories. MarketBeat recorded 26 mentions for Medtronic and 16 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.20 beat Medtronic's score of 1.02 indicating that IDEXX Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medtronic 17 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive IDEXX Laboratories 10 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

IDEXX Laboratories (IDXX) Competitors

$565.18 -10.89 (-1.89%)

As of 12:10 PM Eastern

Compare

IDXX vs. NVST, ABT, ISRG, SYK, and MDT

Should you buy IDEXX Laboratories stock or one of its competitors? MarketBeat compares IDEXX Laboratories with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with IDEXX Laboratories include Envista (NVST), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), and Medtronic (MDT). These companies are all part of the "medical" sector.

How does IDEXX Laboratories compare to Envista?

IDEXX Laboratories (NASDAQ:IDXX) and Envista (NYSE:NVST) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership, media sentiment and valuation.

87.8% of IDEXX Laboratories shares are owned by institutional investors. 0.8% of IDEXX Laboratories shares are owned by insiders. Comparatively, 1.0% of Envista shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

IDEXX Laboratories presently has a consensus target price of $751.00, suggesting a potential upside of 32.88%. Envista has a consensus target price of $28.54, suggesting a potential upside of 6.70%. Given IDEXX Laboratories' stronger consensus rating and higher possible upside, equities research analysts plainly believe IDEXX Laboratories is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

In the previous week, IDEXX Laboratories had 14 more articles in the media than Envista. MarketBeat recorded 16 mentions for IDEXX Laboratories and 2 mentions for Envista. IDEXX Laboratories' average media sentiment score of 1.20 beat Envista's score of 0.72 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	10 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

IDEXX Laboratories has a beta of 1.55, meaning that its share price is 55% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market.

IDEXX Laboratories has higher revenue and earnings than Envista. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	10.36	$1.06B	$13.58	41.62
Envista	$2.72B	1.60	$47M	$0.41	65.23

IDEXX Laboratories has a net margin of 24.63% compared to Envista's net margin of 2.41%. IDEXX Laboratories' return on equity of 70.87% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	24.63%	70.87%	32.56%
Envista	2.41%	7.11%	3.91%

Summary

IDEXX Laboratories beats Envista on 13 of the 15 factors compared between the two stocks.

How does IDEXX Laboratories compare to Abbott Laboratories?

IDEXX Laboratories (NASDAQ:IDXX) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk and dividends.

IDEXX Laboratories has a beta of 1.55, indicating that its share price is 55% more volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market.

IDEXX Laboratories has a net margin of 24.63% compared to Abbott Laboratories' net margin of 13.90%. IDEXX Laboratories' return on equity of 70.87% beat Abbott Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	24.63%	70.87%	32.56%
Abbott Laboratories	13.90%	17.62%	10.01%

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are owned by institutional investors. 0.8% of IDEXX Laboratories shares are owned by insiders. Comparatively, 0.5% of Abbott Laboratories shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Abbott Laboratories had 76 more articles in the media than IDEXX Laboratories. MarketBeat recorded 92 mentions for Abbott Laboratories and 16 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.20 beat Abbott Laboratories' score of 1.02 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	10 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Abbott Laboratories	54 Very Positive mention(s)	11 Positive mention(s)	15 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

IDEXX Laboratories currently has a consensus price target of $751.00, suggesting a potential upside of 32.88%. Abbott Laboratories has a consensus price target of $118.30, suggesting a potential upside of 17.90%. Given IDEXX Laboratories' higher possible upside, research analysts clearly believe IDEXX Laboratories is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.96

Abbott Laboratories has higher revenue and earnings than IDEXX Laboratories. Abbott Laboratories is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	10.36	$1.06B	$13.58	41.62
Abbott Laboratories	$44.33B	3.94	$6.52B	$3.57	28.11

Summary

IDEXX Laboratories beats Abbott Laboratories on 11 of the 17 factors compared between the two stocks.

How does IDEXX Laboratories compare to Intuitive Surgical?

Intuitive Surgical (NASDAQ:ISRG) and IDEXX Laboratories (NASDAQ:IDXX) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

Intuitive Surgical currently has a consensus target price of $523.46, suggesting a potential upside of 48.71%. IDEXX Laboratories has a consensus target price of $751.00, suggesting a potential upside of 32.88%. Given Intuitive Surgical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Intuitive Surgical is more favorable than IDEXX Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intuitive Surgical	1 Sell rating(s)	7 Hold rating(s)	20 Buy rating(s)	1 Strong Buy rating(s)	2.72
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

Intuitive Surgical has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market. Comparatively, IDEXX Laboratories has a beta of 1.55, indicating that its stock price is 55% more volatile than the broader market.

Intuitive Surgical has higher revenue and earnings than IDEXX Laboratories. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intuitive Surgical	$10.06B	12.39	$2.86B	$8.25	42.67
IDEXX Laboratories	$4.30B	10.36	$1.06B	$13.58	41.62

In the previous week, Intuitive Surgical had 79 more articles in the media than IDEXX Laboratories. MarketBeat recorded 95 mentions for Intuitive Surgical and 16 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.20 beat Intuitive Surgical's score of 0.72 indicating that IDEXX Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intuitive Surgical	33 Very Positive mention(s)	13 Positive mention(s)	17 Neutral mention(s)	19 Negative mention(s)	0 Very Negative mention(s)	Positive
IDEXX Laboratories	10 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Intuitive Surgical has a net margin of 28.15% compared to IDEXX Laboratories' net margin of 24.63%. IDEXX Laboratories' return on equity of 70.87% beat Intuitive Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intuitive Surgical	28.15%	15.98%	14.07%
IDEXX Laboratories	24.63%	70.87%	32.56%

83.6% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are owned by institutional investors. 0.6% of Intuitive Surgical shares are owned by company insiders. Comparatively, 0.8% of IDEXX Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Intuitive Surgical beats IDEXX Laboratories on 10 of the 17 factors compared between the two stocks.

How does IDEXX Laboratories compare to Stryker?

Stryker (NYSE:SYK) and IDEXX Laboratories (NASDAQ:IDXX) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

In the previous week, Stryker had 18 more articles in the media than IDEXX Laboratories. MarketBeat recorded 34 mentions for Stryker and 16 mentions for IDEXX Laboratories. Stryker's average media sentiment score of 1.30 beat IDEXX Laboratories' score of 1.20 indicating that Stryker is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stryker	26 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IDEXX Laboratories	10 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Stryker has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market. Comparatively, IDEXX Laboratories has a beta of 1.55, suggesting that its stock price is 55% more volatile than the broader market.

77.1% of Stryker shares are owned by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are owned by institutional investors. 4.6% of Stryker shares are owned by company insiders. Comparatively, 0.8% of IDEXX Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Stryker presently has a consensus price target of $392.52, indicating a potential upside of 22.23%. IDEXX Laboratories has a consensus price target of $751.00, indicating a potential upside of 32.88%. Given IDEXX Laboratories' higher probable upside, analysts plainly believe IDEXX Laboratories is more favorable than Stryker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stryker	0 Sell rating(s)	6 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.78
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

Stryker has higher revenue and earnings than IDEXX Laboratories. Stryker is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stryker	$25.12B	4.90	$3.25B	$8.64	37.17
IDEXX Laboratories	$4.30B	10.36	$1.06B	$13.58	41.62

IDEXX Laboratories has a net margin of 24.63% compared to Stryker's net margin of 13.20%. IDEXX Laboratories' return on equity of 70.87% beat Stryker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stryker	13.20%	23.42%	11.04%
IDEXX Laboratories	24.63%	70.87%	32.56%

Summary

IDEXX Laboratories beats Stryker on 9 of the 17 factors compared between the two stocks.

How does IDEXX Laboratories compare to Medtronic?

Medtronic (NYSE:MDT) and IDEXX Laboratories (NASDAQ:IDXX) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

In the previous week, Medtronic had 10 more articles in the media than IDEXX Laboratories. MarketBeat recorded 26 mentions for Medtronic and 16 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.20 beat Medtronic's score of 1.02 indicating that IDEXX Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medtronic	17 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
IDEXX Laboratories	10 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Medtronic has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market. Comparatively, IDEXX Laboratories has a beta of 1.55, indicating that its share price is 55% more volatile than the broader market.

82.1% of Medtronic shares are held by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are held by institutional investors. 0.3% of Medtronic shares are held by insiders. Comparatively, 0.8% of IDEXX Laboratories shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Medtronic has higher revenue and earnings than IDEXX Laboratories. Medtronic is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medtronic	$36.36B	2.93	$4.80B	$3.73	22.33
IDEXX Laboratories	$4.30B	10.36	$1.06B	$13.58	41.62

IDEXX Laboratories has a net margin of 24.63% compared to Medtronic's net margin of 13.20%. IDEXX Laboratories' return on equity of 70.87% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medtronic	13.20%	14.51%	7.76%
IDEXX Laboratories	24.63%	70.87%	32.56%

Medtronic presently has a consensus price target of $98.21, indicating a potential upside of 17.93%. IDEXX Laboratories has a consensus price target of $751.00, indicating a potential upside of 32.88%. Given IDEXX Laboratories' higher possible upside, analysts clearly believe IDEXX Laboratories is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medtronic	0 Sell rating(s)	10 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.63
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

IDEXX Laboratories beats Medtronic on 11 of the 16 factors compared between the two stocks.

Get IDEXX Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IDXX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IDXX vs. The Competition

Export

Metric	IDEXX Laboratories	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$44.56B	$7.31B	$6.87B	$12.28B
Dividend Yield	N/A	1.33%	2.68%	8.87%
P/E Ratio	41.60	50.41	27.22	23.92
Price / Sales	10.36	81.38	581.69	113.21
Price / Cash	36.92	26.61	49.25	59.89
Price / Book	28.12	7.01	10.72	6.21
Net Income	$1.06B	$162.30M	$3.59B	$331.73M
7 Day Performance	0.29%	-2.43%	-2.12%	-2.18%
1 Month Performance	3.50%	-0.74%	2.12%	-1.53%
1 Year Performance	8.96%	4.54%	24.56%	16.99%

IDEXX Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IDXX IDEXX Laboratories	4.3919 of 5 stars	$565.18 -1.9%	$751.00 +32.9%	+10.7%	$44.56B	$4.30B	41.60	11,000	News Coverage Positive News Analyst Downgrade
NVST Envista	2.0609 of 5 stars	$27.50 -0.5%	$28.67 +4.2%	+37.0%	$4.50B	$2.72B	67.07	12,000
ABT Abbott Laboratories	4.9252 of 5 stars	$95.64 +0.3%	$118.42 +23.8%	-25.0%	$166.17B	$44.33B	26.79	115,000	Trending News Earnings Report Analyst Forecast Options Volume Gap Up
ISRG Intuitive Surgical	4.5684 of 5 stars	$432.83 +1.6%	$571.33 +32.0%	-21.5%	$150.88B	$10.06B	52.46	17,021	Trending News Analyst Forecast Options Volume Gap Down
SYK Stryker	4.8937 of 5 stars	$324.62 -0.6%	$395.10 +21.7%	-15.4%	$125.18B	$25.12B	37.57	56,000	Positive News Options Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IDXX) was last updated on 7/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IDEXX Laboratories (IDXX) Competitors

IDXX vs. NVST, ABT, ISRG, SYK, and MDT

How does IDEXX Laboratories compare to Envista?

Summary

How does IDEXX Laboratories compare to Abbott Laboratories?

Summary

How does IDEXX Laboratories compare to Intuitive Surgical?

Summary

How does IDEXX Laboratories compare to Stryker?

Summary

How does IDEXX Laboratories compare to Medtronic?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IDXX vs. The Competition

IDEXX Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IDEXX Laboratories (IDXX) Competitors

IDXX vs. NVST, ABT, ISRG, SYK, and MDT

How does IDEXX Laboratories compare to Envista?

Do institutionals & insiders hold more shares of IDXX or NVST?

Do analysts prefer IDXX or NVST?

Does the media refer more to IDXX or NVST?

Which has more volatility and risk, IDXX or NVST?

Which has better valuation and earnings, IDXX or NVST?

Is IDXX or NVST more profitable?

Summary

How does IDEXX Laboratories compare to Abbott Laboratories?

Which has more volatility and risk, IDXX or ABT?

Is IDXX or ABT more profitable?

Do insiders & institutionals hold more shares of IDXX or ABT?

Does the media prefer IDXX or ABT?

Do analysts rate IDXX or ABT?

Which has stronger earnings and valuation, IDXX or ABT?

Summary

How does IDEXX Laboratories compare to Intuitive Surgical?

Do analysts prefer ISRG or IDXX?

Which has more risk & volatility, ISRG or IDXX?

Which has preferable valuation and earnings, ISRG or IDXX?

Does the media refer more to ISRG or IDXX?

Is ISRG or IDXX more profitable?

Do institutionals & insiders hold more shares of ISRG or IDXX?

Summary

How does IDEXX Laboratories compare to Stryker?

Does the media refer more to SYK or IDXX?

Which has more volatility & risk, SYK or IDXX?

Do insiders & institutionals believe in SYK or IDXX?

Do analysts rate SYK or IDXX?

Which has better earnings and valuation, SYK or IDXX?

Is SYK or IDXX more profitable?

Summary

How does IDEXX Laboratories compare to Medtronic?

Does the media favor MDT or IDXX?

Which has more risk & volatility, MDT or IDXX?

Do insiders & institutionals hold more shares of MDT or IDXX?

Which has better valuation and earnings, MDT or IDXX?

Is MDT or IDXX more profitable?

Do analysts recommend MDT or IDXX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IDXX vs. The Competition

IDEXX Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools